CompletedPhase 1NCT03585803
A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011
Studying Acute radiation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Intron Biotechnology, Inc.
- Principal Investigator
- Jung-Ryul Kim, MD, PhD, OTSamsung Medical Center
- Intervention
- KMRC011 5μg or Placebo(drug)
- Enrollment
- 26 enrolled
- Eligibility
- 19-55 years · MALE
- Timeline
- 2018 – 2019
Study locations (1)
- Samsung Medical Center, Gangnam-gu, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03585803 on ClinicalTrials.govOther trials for Acute radiation syndrome
Additional recruiting or active studies for the same condition.